StonvexLoading…
StonvexStonvexStonvexCore line items from COO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-10-31 | Annual 2024 2024-10-31 | Annual 2023 2023-10-31 | Annual 2022 2022-10-31 |
|---|---|---|---|---|
Revenue | $4.09B | $3.90B | $3.59B | $3.31B |
Operating Income | $682.90M | $705.70M | $533.10M | $507.60M |
Net Income | $374.90M | $392.30M | $294.20M | $385.80M |
EPS (Diluted) | $1.87 | $1.96 | $1.48 | $1.94 |
Total Assets | $12.39B | $12.32B | $11.66B | $11.49B |
Total Liabilities | $4.16B | $4.23B | $4.11B | $4.32B |
Cash & Equivalents | $110.60M | $107.60M | $120.80M | $138.20M |
Free Cash Flow OCF − CapEx | $433.70M | $288.10M | $215.00M | $450.40M |
Shares Outstanding | 195.90M | 199.60M | 198.10M | 49.30M |